FGF7p
FGF7p is a small molecule peptide and a potential bladder protector. FGF7p can activate downstream signaling pathways of FGFR2 in the urinary tract epithelium (pFRS2α, pAKT and pERK) . FGF7p alleviates cyclophosphamide induced apoptosis and tissue damage in urinary tract epithelial cells by activating AKT and its downstream anti apoptotic targets (pBAD, pS6/mTORC1) . FGF7p has the advantages of low cost, good stability, and high purity. FGF7p is commonly used in the study of inflammatory conditions[1].
Product Specifications
CAS Number
2758194-43-1
UNSPSC
12352209
Target
Akt; Apoptosis; ERK; FGFR; mTOR
Related Pathways
Apoptosis; MAPK/ERK Pathway; PI3K/Akt/mTOR; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt
Field of Research
Inflammation/Immunology
Smiles
Molecular Formula
C95H138N26O28S
Molecular Weight
2124.33
References & Citations
[1]Narla ST, et al. FGF7 peptide (FGF7p) mimetic mitigates bladder urothelial injury from cyclophosphamide. Physiol Rep. 2022 Apr;10 (7) :e15241.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Isoform
Akt; ERK; FGFR2; mTORC1
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Anti-C19orf2/URI1 Antibody Picoband®, Dylight550 Conjugate
